The University of Southampton
University of Southampton Institutional Repository

A single-letter change in an acronym: signals, reasons, promises, challenges, and steps ahead for moving from NAFLD to MAFLD

A single-letter change in an acronym: signals, reasons, promises, challenges, and steps ahead for moving from NAFLD to MAFLD
A single-letter change in an acronym: signals, reasons, promises, challenges, and steps ahead for moving from NAFLD to MAFLD
Introduction: We are currently at the dawn of a revolution in the field of fatty liver diseases. Recently, a consensus recommended ‘metabolic (dysfunction) associated fatty liver disease’ (MAFLD) as a more appropriate name to describe fatty liver disease associated with metabolic dysfunction, ultimately suggesting that the old acronym nonalcoholic fatty liver disease (NAFLD) should be abandoned.

Areas covered: In this viewpoint, we discuss the reasons and relevance of this semantic modification through five different conceptual domains, i.e., 1) signals, 2) reasons, 2) promises, 4) challenges and 5) steps ahead.

Expert opinion: The road ahead will not be traveled without major challenges. Further research to evaluate the positive and negative impacts of the nomenclature change is warranted. However, this modification should encourage increased disease awareness among policymakers and stimulate public and private investments leading to more effective therapy development.
Disease rebranding, metabolic (dysfunction) associated fatty liver disease, nomenclature, nonalcoholic fatty liver disease
1747-4124
345-352
Yilmaz, Yusuf
dc7a129f-9262-4c8a-80db-c53e95f58482
Byrne, Christopher
1370b997-cead-4229-83a7-53301ed2a43c
Musso, Giovanni
1b868e2a-6848-4878-99b9-32808f1bd3b8
Yilmaz, Yusuf
dc7a129f-9262-4c8a-80db-c53e95f58482
Byrne, Christopher
1370b997-cead-4229-83a7-53301ed2a43c
Musso, Giovanni
1b868e2a-6848-4878-99b9-32808f1bd3b8

Yilmaz, Yusuf, Byrne, Christopher and Musso, Giovanni (2020) A single-letter change in an acronym: signals, reasons, promises, challenges, and steps ahead for moving from NAFLD to MAFLD. Expert Review of Gastroenterology & Hepatology, 15 (4), 345-352. (doi:10.1080/17474124.2021.1860019).

Record type: Article

Abstract

Introduction: We are currently at the dawn of a revolution in the field of fatty liver diseases. Recently, a consensus recommended ‘metabolic (dysfunction) associated fatty liver disease’ (MAFLD) as a more appropriate name to describe fatty liver disease associated with metabolic dysfunction, ultimately suggesting that the old acronym nonalcoholic fatty liver disease (NAFLD) should be abandoned.

Areas covered: In this viewpoint, we discuss the reasons and relevance of this semantic modification through five different conceptual domains, i.e., 1) signals, 2) reasons, 2) promises, 4) challenges and 5) steps ahead.

Expert opinion: The road ahead will not be traveled without major challenges. Further research to evaluate the positive and negative impacts of the nomenclature change is warranted. However, this modification should encourage increased disease awareness among policymakers and stimulate public and private investments leading to more effective therapy development.

Text
Accepted manuscript - Accepted Manuscript
Download (114kB)
Text
FIGURE1 - Accepted Manuscript
Download (310kB)
Text
FIGURE2 - Accepted Manuscript
Download (881kB)

More information

Accepted/In Press date: 2 December 2020
e-pub ahead of print date: 9 December 2020
Published date: 9 December 2020
Additional Information: Funding Information: This paper was not funded. The authors thank Kathleen E. Corey (Liver Center, Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA) and Hannes Hagstr?m (Unit of Hepatology, Department of Upper GI, Karolinska University Hospital, Stockholm, Sweden) for helpful discussions. Publisher Copyright: © 2020 Informa UK Limited, trading as Taylor & Francis Group.
Keywords: Disease rebranding, metabolic (dysfunction) associated fatty liver disease, nomenclature, nonalcoholic fatty liver disease

Identifiers

Local EPrints ID: 445576
URI: http://eprints.soton.ac.uk/id/eprint/445576
ISSN: 1747-4124
PURE UUID: 7ec68a12-ba90-4748-8e4f-0477cc62fc85
ORCID for Christopher Byrne: ORCID iD orcid.org/0000-0001-6322-7753

Catalogue record

Date deposited: 16 Dec 2020 17:32
Last modified: 17 Mar 2024 06:09

Export record

Altmetrics

Contributors

Author: Yusuf Yilmaz
Author: Giovanni Musso

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×